KEGG   PATHWAY: map00531Help
Entry
map00531                    Pathway                                

Name
Glycosaminoglycan degradation
Class
Metabolism; Glycan biosynthesis and metabolism
BRITE hierarchy
Pathway map
map00531  Glycosaminoglycan degradation
map00531

Ortholog table
Module
M00076  Dermatan sulfate degradation [PATH:map00531]
M00077  Chondroitin sulfate degradation [PATH:map00531]
M00078  Heparan sulfate degradation [PATH:map00531]
M00079  Keratan sulfate degradation [PATH:map00531]
Disease
H00123  Mucopolysaccharidosis type IV
H00124  GM2 gangliosidoses
H00128  Mucopolysaccharidosis type I
H00129  Mucopolysaccharidosis type II
H00130  Mucopolysaccharidosis type III
H00131  Mucopolysaccharidosis type VI
H00132  Mucopolysaccharidosis type VII
H00133  Mucopolysaccharidosis type IX
H00281  GM1 gangliosidosis
H00421  Mucopolysaccharidosis
H00426  Gangliosidosis
H00753  Urofacial syndrome
H02016  Tay-Sachs disease
H02017  Sandhoff disease
Reference
PMID:27570
  Authors
Greiling H, Stuhlsatz HW, Cantz M, Gehler J
  Title
Increased urinary excretion of keratan sulfate in fucosidosis.
  Journal
J Clin Chem Clin Biochem 16:329-34 (1978)
Reference
PMID:3161730
  Authors
Fuchs W, Beck M, Kresse H
  Title
Intralysosomal formation and metabolic fate of N-acetylglucosamine 6-sulfate from keratan sulfate.
  Journal
Eur J Biochem 151:551-6 (1985)
DOI:10.1111/j.1432-1033.1985.tb09138.x
KO pathway
ko00531   

DBGET integrated database retrieval system